TEL AVIV (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues. [Source]
(Reuters Health) - Social media groups that bring together patients, family, friends and healthcare providers can improve patientsâ€™ outlook and reduce their anxiety and depression, a recent U.S. study suggests.
(Reuters Health) - The U.S. contributes more than any other nation in development assistance for health to low- and middle-income countries, but its generosity falls short when compared in terms of size and wealth, a new study found.
LONDON/FRANKFURT (Reuters) - Generic drugmaker Perrigo has decided to enter the fray for Merck KGaA's consumer health unit, sources told Reuters, and is preparing an indicative offer for the $4.7 billion business ahead of a deadline on Friday.
FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulators' concerns about side effects having frustrated its ambitions almost seven years ago.
(Reuters) - Mehmet Hakan Atilla, a Turkish banker accused of taking part in a scheme to help Iran evade U.S. sanctions, plans to testify in his own defense at his trial in New York, his lawyers said Thursday.
(Reuters Health) - Brain cells - neurons - develop gene mutations over the course of a lifetime, contributing to normal aging and potentially presenting a target for treatments that stave off dementia and other types of cognitive decline, researchers say.
* ONCOSEC ANNOUNCES DOSING OF FIRST PATIENT IN REGISTRATION-DIRECTED PHASE 2B CLINICAL TRIAL, PISCES/KEYNOTE-695, OF IMMUNOPULSEÂ® IL-12 IN COMBINATION WITH PEMBROLIZUMAB Source text for Eikon: Further company coverage: (Bangalore.firstname.lastname@example.org)
NEW YORK/WASHINGTON (Reuters) - For Nancy Minoui of Portland, Oregon, and Crystal Lett of Dublin, Ohio, Congress' failure to fund the Children's Health Insurance Program is not some distant tale of political wrangling.
MANILA (Reuters) - Former Philippine President Benigno Aquino defended on Thursday his decision to implement a controversial immunization program using a new dengue vaccine in 2016, saying it was justified with millions of people at risk of being infected by the virus.
Teen drinking, smoking and drug use overall are stable, but the percentage of teens using marijuana is increasing, according to a new report from the University of Michigan's Institute for Social Research.
SHIJIAZHUANG, China (Reuters) - Severe natural gas shortages are hitting businesses and residents across China's industrial heartland as an unprecedented government effort to clean up an environment devastated by decades of unbridled growth backfires.
Dec 13 (Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases.
CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.
NEW YORK, Dec 13 (Reuters) - Lawyers for a Turkish banker on trial in New York on charges that he helped Iran evade U.S. sanctions asked a judge on Wednesday to declare a mistrial, saying testimony by a former Turkish police investigator should not have been allowed in court.
LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.
CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasichâ€™s desk.
NEW YORK (Reuters) - The Bangladeshi man accused of attempting a suicide bombing in a busy New York City commuter hub will remain in federal custody while he awaits trial on charges that include supporting a foreign terrorist organization, a judge ruled on Wednesday.
TEL AVIV (Reuters) - Reports that Teva Pharmaceutical Industries is planning a restructuring involving mass layoffs in Israel sparked calls on Wednesday for a half-day general strike to be held in protest.
BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.
DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.
(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.
(Reuters) - A surge in shares of Caterpillar and Boeing lifted the Dow industrials to record level in early afternoon trading on Wednesday, ahead of a widely-expected interest rate hike by the Federal Reserve.
NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.
NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance next year surpassed the 1 million mark in the second-to-last week of enrollment on the federally-run HealthCare.gov website, picking up the pace ahead of the Dec. 15 deadline.
Alabama results and the race for Virginia governor this year reflect trends that could bode well for Democrats
Doug Jones became the first Democrat to win a statewide office in Alabama since 2008, defeating Republican Roy Moore, 49.9% to 48.4%, in a special election Tuesday to fill the Senate seat held by Jeff Sessions before he became Donald Trump's Attorney General. Democrats haven't won a Senate race in Alabama since 1992, back when GOP. Sen. Richard Shelby was still a Democrat (he switched parties in 1994).
NEW YORK (Reuters) - More than 1.07 million consumers selected 2018 Obamacare individual insurance plans on the HealthCare.gov website during the week ended Dec. 9, the U.S. government reported on Wednesday, indicating a pick up in the pace of enrollment as the Dec. 15 deadline nears.
STRASBOURG (Reuters) - Doner kebab vendors across Europe won a victory in the European Parliament on Wednesday when European Union lawmakers failed to outlaw additives regularly used to preserve taste and moisture.
TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said.
LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday.
(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products.
MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday.
PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth.
CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.
OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control.
WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans.
(Reuters Health) - Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. â€“ a population at significant risk of contracting the human immunodeficiency virus (HIV) â€“ reported ever using the pill that protects them from the virus, in a recently published study.
(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts.
PARIS (Reuters) - President Emmanuel Macron's labor reforms will be slow to bear fruit but eventually have a massive impact on France's stubbornly high unemployment, his labor minister said Tuesday after data showed a slowdown in new job creation.
LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday.
LONDON (Reuters) - The number of salmonella food poisoning cases in the European Union has risen by 3 percent since 2014 in a "worrying" reversal of a decade-long declining trend, EU health and food safety officials said on Tuesday.
PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters.
GENEVA (Reuters) - Cholera has killed 15 people and made 547 sick in Zambia's capital Lusaka and the rising caseload is expected to grow further as the rainy season starts, according to the World Health Organization.
Dec 12 (Reuters) - U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.
(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.
LAS VEGAS (Reuters) - A U.S. federal judge in the criminal conspiracy trial of Nevada rancher Cliven Bundy and three other men on Monday warned that prosecutors' failure to produce documents that could support defense arguments could lead to a mistrial.
(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.
(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.
(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.
DUBLIN (Reuters) - Pilots employed directly by Ryanair in Dublin, its second largest base, have voted overwhelmingly in favor of taking industrial action in a growing dispute over the airline's collective bargaining system, the IMPACT trade union said on Monday.
Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
LONDON, Dec 11 (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
* HEALTHCARE REALTY TRUST- ON DEC 11, 2017, CO EXPECTS TO COMPLETE SALE OF $300 MILLION AGGREGATE PRINCIPAL AMOUNT OF CO'S 3.625% SENIOR NOTES DUE 2028 Source text: (http://bit.ly/2jvF1sM) Further company coverage:
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
* SAYS IT EXPECTS NET INCOME OF 3.25 BILLION YUAN ($491.16 million) AFTER SELLING 5.5 MILLION SHARES IN ALIBABA GROUP HOLDING Source text in Chinese: http://bit.ly/2B32uI0 Further company coverage: ($1 = 6.6170 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)
JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capitalâ€™s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.
LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.
WELLINGTON (Reuters) - Two brothers who played ice hockey for New Zealand have become the first athletes to be banned after an investigation into the sale of performance-enhancing drugs to amateur sportspeople in the country.
When the Islamic State seized territory in Iraq and Syria, it had the time and space to industrialize advanced weapons manufacturing. The results included explosive space heaters and chemical rockets.
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.
MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.
PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.
(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.
Dec 10 (Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.
(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.
Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.
LOWER MERION, Pa. (Reuters) - In Pennsylvania state Senator Daylin Leach's bid to win a seat vital to the Democratic Party's chances in 2018 elections of taking control of the U.S. Congress, his opponents may not be his biggest obstacle.
LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.
(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.
Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.
(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.
WASHINGTON (Reuters) - U.S. Special Counsel Robert Mueller has turned over more than 400,000 emails, financial records and other documents to defense attorneys for President Donald Trump's former campaign manager Paul Manafort to demonstrate what evidence the government has against him, according to a court filing on Friday.
TORONTO, Dec 8 (Reuters) - Canada's main stock index rose to a two-week high on Friday, led by financial and industrial shares after solid U.S. jobs data boosted investor sentiment, while energy stocks climbed on higher oil prices.
* PLATFORM SPECIALTY PRODUCTS CORPORATION ANNOUNCES FINAL RESULTS OF CASH TENDER OFFER AND CONSENT SOLICITATION FOR, AND COMPLETION OF THE REDEMPTION OF, ANY AND ALL OF ITS OUTSTANDING 10.375% SENIOR NOTES DUE 2021 Source text for Eikon: Further company coverage:
KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.
WASHINGTON (Reuters) - CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.
WASHINGTON, Dec 7 (Reuters) - CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said.
WASHINGTON, Dec 7 (Reuters) - U.S. drugstore chain operator CVS Health Corp expects the Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman said.
(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.
Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.
(Reuters) - Peru's hopes at next year's World Cup finals were dealt a huge blow when captain and all-time record goalscorer Paolo Guerrero was banned for one year on Friday after failing an anti-doping test for cocaine.
SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.
BERLIN (Reuters) - Ten people went on trial in Germany on Friday for alleged failures in planning the "Love Parade" music festival in 2010 when 21 people were killed and more than 650 injured in a stampede.
MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.
VATICAN CITY (Reuters) - The Vatican needs to bring cases of suspected money laundering to trial, a European finance watchdog urged on Friday, saying the good progress made by its financial regulators needed to be matched by judicial muscle.
ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.
(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.
(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.
(Reuters) - New Zealand telecommunications company Spark New Zealand said on Friday its plans for a fifth-generation network (5G) are progressing well and it expects to roll it out within the "next few years."
CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.
WASHINGTON, Dec 7 (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19 with no decision expected before the companies' April 22 deadline to complete the deal, a federal judge said on Thursday.
WASHINGTON (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19, a federal judge in Washington said during a hearing on Thursday.
WASHINGTON, Dec 7 (Reuters) - The trial to determine if the U.S. Department of Justice can stop AT&T Inc's $85 billion purchase of media company Time Warner Inc will begin on March 19, a federal judge in Washington said during a hearing on Thursday.
WASHINGTON (Reuters) - White House Press Secretary Sarah Sanders on Thursday said the United States looks forward to participating in the Olympics Winter Games in South Korea in February, after questions arose about security in the neighbor to North Korea, which has recently ramped up weapons testing.
(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.
JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.
LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.
(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.
BRIEF-Kalytera Therapeutics Says â€Results Of Phase 2 Clinical Study In Prevention Of Graft Versus Host Diseaseâ€‹ Are Expected By Q3 2018
* KALYTERA ANNOUNCES INITIATION OF PHASE 2 CLINICAL STUDY IN PREVENTION OF GRAFT VERSUS HOST DISEASE AND AGREEMENT WITH THE SALZMAN GROUP OF ISRAEL TO MANAGE AND PARTIALLY FUND THE STUDY TO BE LED BY A WORLD CLASS TEAM
(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.
Dec 7 (Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.
WASHINGTON (Reuters) - The U.S. Department of Justice and AT&T Inc will meet in court for the first time on Thursday as the antitrust regulator attempts to stop the U.S. No. 2 wireless company's $85 billion purchase of media company Time Warner Inc .
JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.
ANKARA (Reuters) - The jailed leader of Turkey's pro-Kurdish opposition went on trial on Thursday, 13 months after his arrest on terrorism-related charges, facing up to 142 years in prison in a case closely watched by rights groups and Western governments.
ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.
ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.
(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.
(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.
(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.
WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.
BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.
LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.
(Refiles to add dropped text in final two paragraphs.) By Brendan Pierson NEW YORK, Dec 5 (Reuters) - A Turkish gold trader testifying for U.S. prosecutors in the trial of an executive at Turkey's state-owned Halkbank, who is charged with helping Iran evade U.S. sanctions, said Tuesday that he and the banker never liked each other. Reza Zarrab, who has pleaded guilty and is cooperating with U.S. prosecutors in the case, also said he had complained about Halkbank deputy ge
(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.
SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.
NEW YORK (Reuters) - A Turkish gold trader testifying for U.S. prosecutors in the trial of an executive at Turkey's state-owned Halkbank, who is charged with helping Iran evade U.S. sanctions, said Tuesday that he and the banker never liked each other.
ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.
(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who donâ€™t consume these foods, a recent experiment suggests.